EQT Logo
Current Portfolio

Noema Pharma

Noema Pharma is committed to developing treatments for debilitating disorders of the central nervous system (CNS), conditions characterized by imbalanced neuronal networks leading to unresolved severe symptoms and significant impact on patients’ lives.

Key Facts
Sector

Life Sciences

Country

Switzerland

Fund

LSP 7

Entry

2024

Do You Want to Know More?

We are eager to explore how we can achieve great things together.